Keywords: biovitrum, 1st-qtr, income, falls, 9m, swedish, drugmaker
Biovitrum's 1st-qtr 2008 income falls to $40.9M
Article | 05 May 2008
Swedish drugmaker Biovitrum's first-quarter 2008 revenues amounted to 244.3 million Swedish kronor ($40.9 million) versus 352.9 kronor in the like, year-ago period, as profit ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
